ALGONQUIN, Ill., July 3, 2017 /PRNewswire/ -- Young Innovations ("Young"), a leading global manufacturer and distributorof dental supplies and equipment, today announced the acquisition of VarnishAmerica™ and other product lines from Medical Products Laboratories, Inc. The acquired product lines include VarnishAmerica™ fluoride
"This acquisition further broadens our comprehensive preventive product offering," said Dave Sproat, CEO of Young Innovations. "The VarnishAmerica brand represents a legacy of high-quality fluoride varnish and a commitment to delivering preventive oral care in schools and public health institutions."
"We are proud to announce the continued execution of our focused acquisition strategy in preventive dentistry," added Andrew Jones, Vice President of Corporate Development at Young Innovations. "Our growing portfolio allows us to better support our distributor partners and provide dental professionals with the highest quality products and solutions."
VarnishAmerica™, SealAmerica and FluoriSHIELD™ customers will receive communication from Young ahead of any changes to ordering and customer service processes. Manufacturing of these products will be transitioned to Young's facility in Earth City, MO.
Young Innovations, Inc. is a portfolio company of Linden Capital Partners.
About Young Innovations, Inc.Young Innovations is a leading global manufacturer and distributor of supplies and equipment used by dentists, hygienists, dental assistants and consumers. Our portfolio of brands includes products that hold leadership positions in the preventive, restorative, orthodontic, endodontic and diagnostic segments. With its mission of Creating Smiles, Creating Possibilities, Young focuses on delivering innovative, high-quality products and solutions to clinicians and their patients. We seek out opportunities to enhance our portfolio of brands and products through organic growth and acquisitions.
About Linden Capital PartnersLinden Capital Partners is Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/young-innovations-announces-acquisition-of-varnishamerica-300483136.html
SOURCE Young Innovations
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All